Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005
Official title: To amend title XIX of the Social Security Act to provide for public disclosure of average manufacturer prices (AMP) and best prices for prescription drugs.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005 - Amends title XIX (Medicaid) of the Social Security Act to require the Secretary of Health and Human Services to disclose publicly the average manufacturer prices (AMP) and best prices for prescription drugs.
Requires each drug manufacturer with a rebate agreement in effect to report to the Secretary detailed information (specified by the Secretary) on how the AMP is computed, including assumptions used.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 3546: Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005. 109th Congress. Open America. https://openamerica.io/bill/109-HR-3546/
"H.R. 3546: Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HR-3546/.
H.R. 3546, 109th Cong. (2026), https://openamerica.io/bill/109-HR-3546/.
[H.R. 3546: Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005](https://openamerica.io/bill/109-HR-3546/)